ArticleJournal of pharmaceutical health care and sciences2026

Incidence and clinical characteristics of zolbetuximab-induced nausea and vomiting in CLDN18.2-positive unresectable advanced or recurrent gastric cancer: a retrospective study.

Yosuke Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.